Keith Sutton
Keith Sutton is a Translational Scientist with a strong background in Advanced Therapeutics, specializing in Oncology, Infectious Disease, and Rare Diseases.
He has diverse experience in therapeutic modalities like Gene Therapy, Immunomodulators, ERT, and Cas9 modalities.
Keith obtained a PhD in Virology and a Bachelor of Science (Hons) in Immunology from The University of Edinburgh.
He has held key positions such as Scientific Advisor, Principal Research Scientist, and Senior Research Scientist at Charles River Laboratories.
Keith Sutton has also worked as a Researcher at the University of Dundee, Research Assistant Professor at UMass Medical School, and Lecturer at the University of Newcastle, Australia.
His professional journey includes a role as a Postdoctoral Fellow at MD Anderson Cancer Center.
